Regenera’s stem cell-based therapies are a breakthrough in regenerative medicine, taking advantage of proprietary technology and experience resulting from over 20 years of academic and industry-driven research. Regenera® leverages a deep understanding of stem cell biology to formulate the best indicated stem cells to promote unprecedented musculoskeletal tissue regeneration.
Regenera’s stem cell-based therapies have been widely validated in real clinical cases involving tendon and ligament lesions in high-performance horses and degenerative joint disease in dogs.
Soon, we seek to use our disruptive technology to promote difficult wound healing, peripheral nerve regeneration, amelioration of cardiovascular and auto-immune conditions and many other applications. Regenera® stem cell-based therapies are also showing potential to be applied to humans, so we aim to translate our technology to human medicine.
Our methodology involves the utmost ethics and respect for animal life, and we attempt to restore quality of life and eliminate pain in animals.
Company Details
- Employees
- 6
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.regenerasciences.com
- Keywords
- Coimbra.
Regenera Sciences Questions
Regenera Sciences's website is http://www.regenerasciences.com
Regenera Sciences's LinkedIn profile is https://www.linkedin.com/company/regenera-sciences
Regenera Sciences has
6 employees.
View email and phone details for 6
employees at Regenera Sciences.
Regenera Sciences's industry is
Biotechnology Research
Regenera Sciences's top competitors are
Tekever,
Rows.com,
Ges Africa Conservation Fund Usa Inc,
Clínica Veterinária De Loulé,
Active Site Consulting, Lda.,
Dropdepot,
Wiseflow,
Tactical Africa Conservation K9,
Tinta Pertinente,
Winalist.
Regenera Sciences's categories are Biotechnology Research
